Neo Ivy Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.34M Buy
473,105
+194,310
+70% +$2.17M 1% 9
2026
Q1
$3.02M Buy
278,795
+177,127
+174% +$1.52M 0.8% 28
2025
Q4
$621K Sell
101,668
-47,652
-32% -$284K 0.1% 199
2025
Q3
$773K Sell
149,320
-29,264
-16% -$168K 0.19% 179
2025
Q2
$1.06M Buy
178,584
+108,472
+155% +$653K 0.34% 114
2025
Q1
$576K Buy
70,112
+26,024
+59% +$218K 0.18% 152
2024
Q4
$364K Buy
+44,088
New +$354K 0.07% 179
2023
Q4
$40K Buy
+3,692
New +$44.9K 0.09% 199
2022
Q4
– Sell
-2,289
Closed -$27K – 511
2022
Q3
$27K Buy
+2,289
New +$32.7K 0.07% 276

Other funds holding PTEN

Neo Ivy Capital Management's PTEN Position: Q2 2026 in Review

Neo Ivy Capital Management increased its Patterson-UTI (PTEN) stake by 70% in Q2 2026, buying an estimated $2.17M and bringing the position to 473,105 shares worth $4.34M. The position accounts for 1% of the portfolio, ranked #9.

Neo Ivy Capital Management first reported a position in PTEN in Q3 2022 and has held it in 9 quarters since. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Neo Ivy Capital Management held 473,105 shares of Patterson-UTI worth $4.34M as of Q2 2026.
  • Neo Ivy Capital Management bought 194,310 Patterson-UTI shares in Q2 2026, an estimated $2.17M.
  • Patterson-UTI made up 1% of Neo Ivy Capital Management's portfolio in Q2 2026, its #9 holding.
  • Neo Ivy Capital Management first reported a position in Patterson-UTI in Q3 2022 and has held it in 9 quarters since.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.